Anomaly Bio uses fungal-derived proteins and a novel biomanufacturing technique to deliver a protein-rich, abundant, sustainable, cost-effective, and healthful source of nutrition. The company initially focuses on pet nutrition, with long-term expansion plans into cosmetics, human foods, and pharmaceuticals.

Anomaly Bio's biomanufacturing approach leverages fungi to create alternative protein sources that are environmentally sustainable and scalable, addressing the growing demand for sustainable nutrition solutions across multiple industries.